Loading...
Biopharma Budget And Pricing Will Curb Margins But Yield Promise
AnalystLowTarget's Fair Value
US$20.00
20.7% undervalued intrinsic discount10 Sep
US$15.86
1Y
-50.8%7D
10.4%1Y
-50.8%7D
10.4%You can edit this narrative until Jun 22 11:39 PM. Then, changes will post as Updates.